Advanced Search: Targets | Target Pharmacology | Ligands | Chemical Structure
Current Release Version 2021.3 (2nd Sep 2021). Read our release notes blog.
Themed includes IUPHAR Review 29:
A rational roadmap for SARS‐CoV‐2/COVID‐19 pharmacotherapeutic research and development, which made the cover of the issue.
Levi-Schaffer F, de Marco A (2021) Br J Pharmacol. Online ahead of print. doi: 10.1111/bph.15359.
Illes P, Müller CE, Jacobson KA, Grutter T, Nicke A, Fountain SJ, Kennedy C, Schmalzing G, Jarvis MF, Stojilkovic SS, King BF, Di Virgilio F. (2021) Br J Pharmacol. 178(3):489-514. doi: 10.1111/bph.15299.
Gregory KJ, Goudet C (2021) Pharmacol Rev. 73: 521-569.
Barnes NM, Ahern GP, Becamel C, Bockaert J, Camilleri M, Chaumont-Dubel S, Claeysen S, Cunningham KA, Fone KC, Gershon M, Di Giovanni G, Goodfellow NM, Halberstadt AL, Hartley RM, Hassaine G, Herrick-Davis K, Hovius R, Lacivita E, Lambe EK, Leopoldo M, Levy FO, Lummis SCR, Marin P, Maroteaux L, McCreary AC, Nelson DL, Neumaier JF, Newman-Tancredi A, Nury H, Roberts A, Roth BL, Roumier A, Sanger GJ, Teitler M, Sharp T, Villalón CM, Vogel H, Watts SW, Hoyer D (2021) Pharmacol Rev. 73: 310-520.
ACCEPT COOKIES